Lilly to seek accelerated FDA approval for Alzheimer’s drug this year



This content originally appeared on Reuters and was authored by Reuters


This content originally appeared on Reuters and was authored by Reuters


Print Share Comment Cite Upload Translate Updates
APA

Reuters | Sciencx (2021-06-24T15:40:00+00:00) Lilly to seek accelerated FDA approval for Alzheimer’s drug this year. Retrieved from https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/

MLA
" » Lilly to seek accelerated FDA approval for Alzheimer’s drug this year." Reuters | Sciencx - Thursday June 24, 2021, https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/
HARVARD
Reuters | Sciencx Thursday June 24, 2021 » Lilly to seek accelerated FDA approval for Alzheimer’s drug this year., viewed ,<https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/>
VANCOUVER
Reuters | Sciencx - » Lilly to seek accelerated FDA approval for Alzheimer’s drug this year. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/
CHICAGO
" » Lilly to seek accelerated FDA approval for Alzheimer’s drug this year." Reuters | Sciencx - Accessed . https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/
IEEE
" » Lilly to seek accelerated FDA approval for Alzheimer’s drug this year." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/. [Accessed: ]
rf:citation
» Lilly to seek accelerated FDA approval for Alzheimer’s drug this year | Reuters | Sciencx | https://www.scien.cx/2021/06/24/lilly-to-seek-accelerated-fda-approval-for-alzheimers-drug-this-year/ |

Please log in to upload a file.




There are no updates yet.
Click the Upload button above to add an update.

You must be logged in to translate posts. Please log in or register.